n y c
عضو نشط
- التسجيل
- 19 مارس 2006
- المشاركات
- 227
السلام عليكم
هل هذا السهم اقدر اقول علية نشف دمة وهو فرصة للشراء
افيدونا وهذة اخر اخباره ومعلوماتة
vexp
VELOCITY EXPRESS NEW (NasdaqSC:VEXP) Delayed quote data
Last Trade: 1.83
Trade Time: 11:31AM ET
Change: 0.01 (0.54%)
Prev Close: 1.84
Open: 1.91
Bid: 1.83 x 2000
Ask: 1.84 x 3400
1y Target Est: N/A
Day's Range: 1.76 - 1.91
52wk Range: 1.53 - 18.50
Volume: 9,930
Avg Vol (3m): 197,771
Market Cap: 30.06M
P/E (ttm): N/A
EPS (ttm): -5.97
Div & Yield: N/A (N/A)
-Mar-2006
Change in Directors or Principal Officers
ITEM 5.02 Departure of Directors or Principal Officers; Election of Directors;
appointment of Principal Officers.
(b)
The Company announced the departure of Daniel DeFazio, effective March 6, 2006, who served as the Company's Chief Financial Officer since January 2005.
(c)
Effective March 6, 2006, Edward W. Stone was appointed by the Board of Directors of Velocity Express Corporation (the "Company") to serve as the Company's Chief Financial Officer. Mr. Stone, 52, joins Velocity with nearly 30 years of experience as a corporate financial executive within multi-billion dollar companies as well as smaller publicly-traded and privately-held companies in a range of industries, all of which differentiated themselves in their markets through superior technology-driven product development and service delivery. His prior CFO assignments include Solucient, a leading supplier of information to the healthcare industry, where from 2001 to 2003 he helped integrate four predecessor companies and fund the product and service improvements that allowed the company to resume profitable sales growth. Since 2003, Mr. Stone has been active providing CFO consulting services to mid-sized and early-stage companies in the software, information and manufacturing industries. From 1998 to 2000, Stone was CFO for Executone Information Systems, Inc. (formerly NASDAQ: XTON) and Acting CEO for Executone's Healthcare Systems division. From 1995 to 1998, he served as Vice President, Finance for a $2 billion group within The Thomson Corporation, and from 1993 to 1995, Mr. Stone was Chief Financial & Administrative Officer for Krueger International, a leading manufacturer of office furniture. Previously, Mr. Stone was employed from 1988 to 1993 by the Searle Pharmaceuticals subsidiary of The Monsanto Company. He joined Searle as Corporate Controller and was promoted to Vice President, Finance with responsibility for Searle's controllership, treasury, tax and information technology operations. He began his career with Pfizer, Inc. in 1976, where he spent seven years in a variety of increasingly responsible positions, including the last three and a half years as Controller for Pfizer's Roerig Division.
Mr. Stone has an employment at-will contract with the Company that is attached as an exhibit to this Form 8-K. The agreement provides for annual base compensation of $300,000 and benefits consistent with the Company's regular benefit programs. Base salary increases, if any, will be reviewed annually by the Compensation Committee of the Company's Board of Directors , which will assess officer and company performance.
The employment agreement provides that a severance payment equal to 6 months of base salary (and a pro-rata portion of any bonus earned as of the date of termination) will be made if Mr. Stone's employment is terminated by our company without cause. In addition to the foregoing severance payments, we have agreed to pay or reimburse Mr. Stone for medical (COBRA) benefits for the period covered by the severance payments. In addition, Mr. Stone has agreed to certain nondisclosure provisions during the term of his employment and any time thereafter, and certain noninterference and nonrecruitment provisions during the term of his employment and for a period of one year thereafter.
There are no family relationships between directors or executive officers of the Company. Each of the Company's executive officers is appointed to serve until his or her successor is duly appointed, or his or her earlier removal or resignation from office.
ومن يبي الترجمة حاظرين
ابو وليد
هل هذا السهم اقدر اقول علية نشف دمة وهو فرصة للشراء
افيدونا وهذة اخر اخباره ومعلوماتة
vexp
VELOCITY EXPRESS NEW (NasdaqSC:VEXP) Delayed quote data
Last Trade: 1.83
Trade Time: 11:31AM ET
Change: 0.01 (0.54%)
Prev Close: 1.84
Open: 1.91
Bid: 1.83 x 2000
Ask: 1.84 x 3400
1y Target Est: N/A
Day's Range: 1.76 - 1.91
52wk Range: 1.53 - 18.50
Volume: 9,930
Avg Vol (3m): 197,771
Market Cap: 30.06M
P/E (ttm): N/A
EPS (ttm): -5.97
Div & Yield: N/A (N/A)
-Mar-2006
Change in Directors or Principal Officers
ITEM 5.02 Departure of Directors or Principal Officers; Election of Directors;
appointment of Principal Officers.
(b)
The Company announced the departure of Daniel DeFazio, effective March 6, 2006, who served as the Company's Chief Financial Officer since January 2005.
(c)
Effective March 6, 2006, Edward W. Stone was appointed by the Board of Directors of Velocity Express Corporation (the "Company") to serve as the Company's Chief Financial Officer. Mr. Stone, 52, joins Velocity with nearly 30 years of experience as a corporate financial executive within multi-billion dollar companies as well as smaller publicly-traded and privately-held companies in a range of industries, all of which differentiated themselves in their markets through superior technology-driven product development and service delivery. His prior CFO assignments include Solucient, a leading supplier of information to the healthcare industry, where from 2001 to 2003 he helped integrate four predecessor companies and fund the product and service improvements that allowed the company to resume profitable sales growth. Since 2003, Mr. Stone has been active providing CFO consulting services to mid-sized and early-stage companies in the software, information and manufacturing industries. From 1998 to 2000, Stone was CFO for Executone Information Systems, Inc. (formerly NASDAQ: XTON) and Acting CEO for Executone's Healthcare Systems division. From 1995 to 1998, he served as Vice President, Finance for a $2 billion group within The Thomson Corporation, and from 1993 to 1995, Mr. Stone was Chief Financial & Administrative Officer for Krueger International, a leading manufacturer of office furniture. Previously, Mr. Stone was employed from 1988 to 1993 by the Searle Pharmaceuticals subsidiary of The Monsanto Company. He joined Searle as Corporate Controller and was promoted to Vice President, Finance with responsibility for Searle's controllership, treasury, tax and information technology operations. He began his career with Pfizer, Inc. in 1976, where he spent seven years in a variety of increasingly responsible positions, including the last three and a half years as Controller for Pfizer's Roerig Division.
Mr. Stone has an employment at-will contract with the Company that is attached as an exhibit to this Form 8-K. The agreement provides for annual base compensation of $300,000 and benefits consistent with the Company's regular benefit programs. Base salary increases, if any, will be reviewed annually by the Compensation Committee of the Company's Board of Directors , which will assess officer and company performance.
The employment agreement provides that a severance payment equal to 6 months of base salary (and a pro-rata portion of any bonus earned as of the date of termination) will be made if Mr. Stone's employment is terminated by our company without cause. In addition to the foregoing severance payments, we have agreed to pay or reimburse Mr. Stone for medical (COBRA) benefits for the period covered by the severance payments. In addition, Mr. Stone has agreed to certain nondisclosure provisions during the term of his employment and any time thereafter, and certain noninterference and nonrecruitment provisions during the term of his employment and for a period of one year thereafter.
There are no family relationships between directors or executive officers of the Company. Each of the Company's executive officers is appointed to serve until his or her successor is duly appointed, or his or her earlier removal or resignation from office.
ومن يبي الترجمة حاظرين
ابو وليد
